[Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
D000293:Adolescent; D000328:Adult; D000936:Antigen-Antibody Complex / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D001379:Azathioprine / Q000008:administration & dosage*; D002648:Child; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004247:DNA / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D003520:Cyclophosphamide; D003165:Complement System Proteins; D004247:DNA; D001379:Azathioprine; D011241:Prednisone
Wpływ leczenia enkortonem oraz cytostatykami na wybrane wskaźniki immunologiczne u chorych toczeń rumieniowaty układowy.